optimization of cmas & cpps of “suspension homogenization process” using box behnken rsm for...

5
FOR LIQUID ORAL DOSAGE FORM DEVELOPMENT AS PER QbD OPTIMIZATION OF CMAs & CPPs OF SUSPENSION HOMOGENIZATION PROCESS QUALITY COMPROMISED EFFICACY COMPROMISED SAFETY COMPROMISED INADEQUATE ZETA POTENTIAL RISKS INADEQUATE VISCOSITY HIGH RATE OF SEDIMENTATION CONTENT UNIFORMITY COMPROMISED FACTORIAL MIXTURE CENTRAL COMPOSITE RESPONSE SURFACE BOX BEHNKEN A B C STIRRING TIME HYDROCOLLOID SURFACTANT DEVELOPMENT OF DESIGN SPACE ANALYSIS OF RESPONSES DESIGN OF EXPERIMMENTS IDENTIFICATION OF FACTORS CASE STUDY 16 © Created & Copyrighted by Shivang Chaudhary SHIVANG CHAUDHARY Created & Copyrighted by: Quality Risk Manager & Intellectual Property Sentinel- CIIE, IIM Ahmedabad, INDIA MS Pharm (Pharmaceutics)-NIPER, PGD (Patents Law)-NALSAR [email protected]

Upload: shivang-chaudhary

Post on 12-Aug-2015

111 views

Category:

Healthcare


1 download

TRANSCRIPT

FOR LIQUID ORAL DOSAGE FORM DEVELOPMENT AS PER QbD

OPTIMIZATION OF CMAs & CPPs OF SUSPENSION HOMOGENIZATION PROCESS

QUALITY COMPROMISED EFFICACY COMPROMISED SAFETY COMPROMISED

INADEQUATE ZETA POTENTIAL

RISKS

INADEQUATE VISCOSITY HIGH RATE OF SEDIMENTATION

CONTENT UNIFORMITY COMPROMISED

FACTORIAL MIXTURE

CENTRAL COMPOSITE

RESPONSE SURFACE

BOX BEHNKEN

A

B

C STIRRING TIME

HYDROCOLLOID

SURFACTANT

DEVELOPMENT OF DESIGN SPACE

ANALYSIS OF RESPONSES

DESIGN OF EXPERIMMENTS

IDENTIFICATION OF FACTORS

CA

SE

STU

DY

16

© Created & Copyrighted by Shivang Chaudhary

SHIVANG CHAUDHARY Created & Copyrighted by:

Quality Risk Manager & Intellectual Property Sentinel- CIIE, IIM Ahmedabad, INDIA MS Pharm (Pharmaceutics)-NIPER, PGD (Patents Law)-NALSAR

[email protected]

Factors (Variables) Levels of Factors Studied -1 0 +1

A HYDROCOLLOID (%) 20%w/w 30%w/w 40%w/w B SURFACTANT (%) 0.50%w/w 1.00%w/w 1.50%w/w C STIRRING TIME (min) 30min 45min 60min

NO. OF FACTORS

NO. OF LEVELS

EXPERIMENTAL DESIGN SELECTED

ADD. CENTER POINTS

TOTAL NO OF EXPERIMENTAL RUNS (NO OF TRIALS)

3

3

BOX BEHNKEN DESIGN

2

12MP + 3CP

=15

To Optimize CMAs & CPPs of Liquid Suspension Dosage Form OBJECTIVE

DEVELOPMENT OF DESIGN SPACE

ANALYSIS OF RESPONSES

FACTORIAL MIXTURE

CENTRAL COMPOSITE

RESPONSE SURFACE

BOX BEHNKEN

IDENTIFICATION OF FACTORS

DESIGNING OF EXPERIMMENTS

OPTIMIZATION OF CMAs & CPPs OF SUSPENSION HOMOGEMIZATION

A HYDROCOLLOID

C

STIR

RIN

G T

IME

CA

SE

STU

DY

16

© Created & Copyrighted by Shivang Chaudhary

PREDICTION EFFECT EQUATION OF EACH FACTOR, THEIR INTERACTIONS & CURVATURES ON INDIVIDUAL RESPONSE BY QUADRATIC MODEL

Sedimentation Volume Ratio =+0.037-0.013A-0.068B-0.033C+0.010 AB+0.010AC+0.015BC+0.042A2+0.13B2+0.047C2

Zeta Potential =-42.00-1.75A-19.38B-6.63C+2.25AB-1.25AC+7.00BC-1.75A2+5.00B2-2.50C2

Viscosity=+45.00+1.88A+16.13B+6.00C+0.75AB+0.50AC +0.000BC+0.38A2+0.38B2-1.38C2

Content Uniformity=+1.73-0.075A-0.14B-0.24C-0.025AB+0.075AC+0.050BC+0.28A2+0.46B2+0.51C2

CQAs CMAs CPP

DEVELOPMENT OF DESIGN SPACE

FACTORIAL MIXTURE

CENTRAL COMPOSITE

RESPONSE SURFACE

BOX BEHNKEN

IDENTIFICATION OF FACTORS

DESIGNING OF EXPERIMMENTS

ANALYSIS OF RESPONSES

OPTIMIZATION OF CMAs & CPPs OF SUSPENSION HOMOGEMIZATION

CA

SE

STU

DY

16

© Created & Copyrighted by Shivang Chaudhary

IDENTIFICATION OF FACTORS

DESIGNING OF EXPERIMMENTS

Responses (Effects) Goal for Individual Responses Y1 Sedimentation Volume Ratio To achieve the minimum SVR i.e. NMT 0.1 Y2 Zeta Potential (mV) To achieve zeta potential of suspension in the range of -35 to -45 mv Y3 Viscosity (cps) To achieve viscosity in the range of 40 to 50 cps Y4 Content Uniformity (AV) To achieve minimum acceptance value in CU i.e. NMT 2.0

Factors (Variables) Knowledge Space Design Space Control Space A HYDROCOLLOID (%) 20.0-40.0 27.5-32.5 28.0-32.0 B SURFACTANT (%) 0.50-1.50 0.60-1.40 0.75-1.25 C STIRRING TIME (min) 30-60 37-53 40-50

ANALYSIS OF RESPONSES

FACTORIAL MIXTURE

CENTRAL COMPOSITE

RESPONSE SURFACE

BOX BEHNKEN

DEVELOPMENT OF DESIGN SPACE

OPTIMIZATION OF CMAs & CPPs OF SUSPENSION HOMOGEMIZATION

CA

SE

STU

DY

16

© Created & Copyrighted by Shivang Chaudhary

THANK YOU SO MUCH FROM

DESIGN IS A JOURNEY OF DISCOVERY…

© Created & Copyrighted by Shivang Chaudhary

SHIVANG CHAUDHARY

© Copyrighted by Shivang Chaudhary

Quality Risk Manager & Intellectual Property Sentinel- CIIE, IIM Ahmedabad MS (Pharmaceutics)- National Institute of Pharmaceutical Education & Research (NIPER), INDIA

PGD (Patents Law)- National academy of Legal Studies & Research (NALSAR), INDIA

+91 -9904474045, +91-7567297579 [email protected]

https://in.linkedin.com/in/shivangchaudhary

facebook.com/QbD.PAT.Pharmaceutical.Development